Sign In
Last checked at 
9 Sep 2021 11:23
Creo Medical Group plc
("Creo" or the "Company")
Director/PDMR Shareholding
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that Charles Spicer, Non-Executive Chairman, purchased 9,657 Ordinary Shares through the Open Offer at the Offer Price of 182.5 pence per Ordinary Share via his Self-Invested Personal Pension ('SIPP'). Following this purchase and Admission of the New Ordinary Shares on 7 September 2021 Charles Spicer holds 127,976 Ordinary Shares in the Company via his SIPP, representing approximately 0.07% of the Company's issued share capital.
Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular dated 16 August 2021.
Creo Medical Group plc | investors.creomedical.com |
Richard Rees (CFO) | +44 (0)1291 606 005 |
|
|
Cenkos Securities plc | +44 (0)20 7397 8900 |
Stephen Keys / Camilla Hume (NOMAD) |
|
Michael Johnson / Russell Kerr (Sales) |
|
|
|
Walbrook PR Ltd | Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com |
Paul McManus / Lianne Cawthorne | Mob: +44 (0)7980 541 893 / +44 (0)7515 909 238 |
The information below, set out in accordance with the requirements of the MAR, provides further detail.
ANNEX
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
|
Charles Spicer | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Chairman | ||||
b)
| Initial notification /Amendment | Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Creo Medical Group plc | ||||
b)
| LEI
| 213800H188ZDCWWXFA21 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of £0.001 each
GB00BZ1BLL44
| ||||
b)
| Nature of the transaction
| Purchase of shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
N/A
| ||||
e)
| Date of the transaction
| 7 September 2021 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
Follow the stocks
